NCT04378842View on ClinicalTrials.gov

COVID-19 and ICU-acquired MDR Bacteria

CompletedOBSERVATIONAL
Enrollment

368

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

July 26, 2021

Study Completion Date

July 26, 2021

Conditions
Sars-CoV2Critical Illness
Trial Locations (7)

59037

Hôpital Roger Salengro, ICU, CHU Lille, Lille

Unknown

Chu Amiens Picardie, Amiens

Ch Bethune, Béthune

Grand Hopital de L'Est Francilien, Jossigny

CH LENS, Lens

Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse), Lyon

Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT04378842 - COVID-19 and ICU-acquired MDR Bacteria | Biotech Hunter | Biotech Hunter